ADARx Pharmaceuticals, Inc.

About ADARx Pharmaceuticals, Inc.

ADARx Pharmaceuticals is dedicated to advancing next-generation RNA therapeutics to conquer diseases at their core. Their mission is to deliver potent, precise RNA medicines that make a meaningful difference for patients with chronic diseases, leveraging cutting-edge RNA technology and proprietary targeted delivery platforms.

Products & Services

RNA Therapeutics:A diverse clinical-stage pipeline of RNA medicines designed to address unmet needs in genetic, complement-mediated, cardiovascular, cardiometabolic, central nervous system, and metabolic diseases, with improved potency, precision, and durability.

Specialties

RNA Science Targeted Delivery Platforms Next-Generation RNA Therapeutics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 200000000 MR: - FA: $200 million FAN: 200000000	D: 2023-08-09 FD: 2023-08-09	16 investors
2	RT: Series B-1 T: - FT: Series B-1	A: 46000000 MR: - FA: $46 million FAN: 46000000	D: 2023-01-20 FD: 2023-01-20	5 investors

Series C Latest

2023-08-09

$200.0M

16 investors (Pro only)

Series B-1 2023-01-20

$46.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

Z

Zhen Li

President & CEO

C

Christopher Claeboe

Senior Vice President of Operations

R

Robert A. MacLeod

Chief Scientific Officer

A

Ajim Tamboli

Chief Financial Officer

R

Rui Zhu

Senior Vice President, Research

L

Laura Shawver

Board Chair

View 10 more team members with Pro

Unlock Full Team Directory

Recent News